REG - East Imperial PLC - Notice of GM and Capital Reorganisation

East ImperialAnnouncement

02/02/2024 12:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240202:nRSB8983Ba&default-theme=true

RNS Number : 8983B  East Imperial PLC  02 February 2024

The information contained within this announcement is deemed by the Company to
constitute inside information pursuant to Article 7 of EU Regulation 596/2014
as it forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 as amended.

2 February 2024

East Imperial plc

("East Imperial" or the "Company")

 

Notice of General Meeting

Capital Reorganisation

East Imperial, the global purveyor of super-premium beverages, announces that
further to its announcement on 24 January 2024, it will today post to
shareholders a circular containing a notice of general meeting ("GM") to renew
authorities to allot new ordinary shares, as well as to change the nominal
value of ordinary shares.

Notice of GM

As announced on 24 January 2024, the Company raised approximately £325,000 by
way of a placing of 29,545,454 ordinary shares ("Placing Shares") with one
investor ("Placing"). Establishing the Company's US base and distributors has
taken longer than planned, and with sales in China growing slower than
expected, the Company's cash flow break-even point is now expected to occur
later than anticipated. Therefore, the Company requires additional working
capital to finance operations during 2024. The net proceeds of the Placing
have provided the Company with a cash runway until April 2024.

Following the allotment of the Placing Shares, the Company's remaining
authority to allot further shares on a non pre-emptive basis has been reduced
to 4,271,650 ordinary shares of one penny each ("Existing Ordinary Shares"),
which the Board considers insufficient in light of the Company's future
working capital requirements. As indicated in the announcement of 24 January
2024, the Board has therefore decided to convene a GM to obtain additional
authorities to allot shares on a non pre-emptive basis in order to provide the
Company with the ability to issue shares for working capital for the period
after April 2024. In addition, subject to shareholder approval, the Board
proposes to reduce the nominal value of ordinary shares ("Capital
Reorganisation") to provide the Board with the flexibility it considers
necessary to facilitate future fundraises by the Company, details of which are
set out further below.

A circular, which includes notice of the GM, will be sent to shareholders
today to convene a general meeting at 11:00 a.m. on 19 February 2024 at the
offices of Fasken Martineau LLP, 100 Liverpool Street, London, EC2M 2AT. The
purpose of the GM is to: (i) seek shareholder approval to a Capital
Reorganisation, which will also require amendments to the Company's articles
of association; and (ii) obtain further authorities to enable the Board to
allot shares on a non pre-emptive basis.

The Directors of the Company consider that all the resolutions to be
considered at the GM are in the best interests of the Company and its members
as a whole. The Directors unanimously recommend that shareholders vote in
favour of all the resolutions as they intend to do in respect of their own
beneficial holdings.

If the resolutions are not approved by shareholders, the Company's ability to
raise additional working capital through equity will be restricted and
therefore the performance, financial position and prospects of the Company
could be adversely affected and alternative funding solutions will need to be
sought.

Capital Reorganisation

As the Company is not permitted by law to issue shares at an issue price which
is below their nominal value, the Company's ability to raise funds from
investors is limited due to the proximity of the mid-market price of the
shares to their nominal value. Whilst the Board's objective is to achieve the
highest possible issue price for the Company when issuing shares, it is
cognisant that, given current market conditions, the Company may be unable to
issue shares at a sufficient discount to their market price in order to
attract further equity investment into the business.

In order to enable the Company to issue shares at an issue price which exceeds
their nominal value, shareholder approval is being sought to complete a
Capital Reorganisation.

The Capital Reorganisation will involve:

·      each of the existing ordinary shares of one penny each will be
subdivided into and reclassified as one New Ordinary Share (defined below) and
one Deferred Share (defined below);

·     each New Ordinary Share will be an ordinary share in the capital
of the Company with a nominal value of £0.001 (0.1 pence); and

·    each Deferred Share will be a deferred share in the capital of the
Company with a nominal value of £0.009 (0.9 pence).

Subject to the passing of the relevant resolutions at the AGM, the Capital
Reorganisation will take effect at the close of business on the date of the GM
("Record Date").

As a consequence of, and immediately following, the Capital Reorganisation
becoming effective each Shareholder's holding of New Ordinary Shares will be
the same as the number of Existing Ordinary Shares held by them on the Record
Date. Each shareholder's proportionate interest in the Company's issued
ordinary share capital will, and thus the aggregate value of their holding
should, remain unchanged as a result of the Capital Reorganisation.

The New Ordinary Shares will have the same rights as those currently accruing
to the Existing Ordinary Shares in issue under the articles of association of
the Company, including those relating to voting and entitlement to dividends.

The Deferred Shares created will be effectively valueless as they will not
carry any rights to vote or dividend rights. The Deferred Shares will not be
traded on the London Stock Exchange's ("LSE") Main Market for listed
securities or listed and will not be transferable without the prior written
consent of the Board. No share certificates will be issued in respect of the
Deferred Shares, nor will CREST accounts of Shareholders be credited in
respect of any entitlement to Deferred Shares.

The intention is that Deferred Shares would be cancelled in due course
following a court approved reduction of capital or other means, if available.

Admission

Application has been made to the UK Financial Conduct Authority ("FCA") and
the LSE for the New Ordinary Shares to be admitted to the standard segment of
the FCA Official List and to trading on the LSE's Main Market for listed
securities ("Admission"). Admission is expected to occur at 8.00 a.m. on or
around 20 February 2024.

Total Voting Rights

Following Admission of the New Ordinary Shares, assuming no other issue of New
Ordinary Shares takes place (such as from the exercise of any convertible
securities) prior to the General Meeting, the total issued share capital of
the Company with voting rights will comprise 367,716,497 New Ordinary Shares.

The Company does not hold any Ordinary Shares in treasury. Therefore,
following Admission of the New Ordinary Shares, the above figure of
367,716,497 New Ordinary Shares may be used by Shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the share capital
of the Company under the FCA's Disclosure, Guidance and Transparency Rules.

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 Publication of circular and Notice of GM                                        2 February 2024
 Latest time and date for voting by proxy for GM                                 11.00 a.m. on 15 February 2024
 General Meeting                                                                 19 February 2024
 Announcement of the result of the GM                                            19 February 2024
 Record Date and final date and time for trading in Existing Ordinary Shares     6.00 p.m. on 19 February 2024
 Expected date of Admission of the New Ordinary Shares arising from the Capital  20 February 2024
 Reorganisation

 

KEY STATISTICS RELATING TO THE CAPITAL REORGANISATION

 Prior to the Capital Reorganisation
 Number of Existing Ordinary Shares     367,716,497
 Post Capital Reorganisation
 Number of New Ordinary Shares          367,716,497
 Number of Deferred Shares              367,716,497
 ISIN code for the New Ordinary Shares  GB00BMZ1ND56

 

 

For further information, please contact:

 East Imperial plc                                           investors@eastimperial.com (mailto:investors@eastimperial.com)

 Anthony Burt

 Robin Stevens

 Allenby Capital Limited (Broker)                            +44 (0)20 3328 5656

 Guy McDougall / Matt Butlin (Sales and Corporate Broking)

 Jeremy Porter / Piers Shimwell (Corporate Finance)

 

About East Imperial

Founded in New Zealand and Singapore in 2012, East Imperial produces a range
of super-premium mixers that sell throughout APAC, the US and EMEA. Guided by
a clear strategy to capitalise on the growing demand for premiumisation across
the beverage industry, East Imperial has sold over 32 million bottles in over
20 countries since its founding, with popular products including Old World
Tonic Water, Grapefruit Tonic Water, Yuzu Tonic Water and Mombasa Ginger Beer.
In 2023, East Imperial won 9 medals at the coveted Tonic & Mixers Masters
Competition in London. The Company was founded on the philosophy of creating
exquisite products defined by heritage, tradition, and authenticity. All
products are made from high quality, all-natural ingredients, reflecting East
Imperial's commitment to providing a sustainable product and minimising
environmental impacts at every stage of the manufacturing process. For more
information about East Imperial and its premium mixers. Visit
https://www.eastimperial.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOGBDGDDIBGDGSD